NCT06948955 2026-04-02
Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Available
Cogent Biosciences, Inc.
SpringWorks Therapeutics, Inc.
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Aveni Foundation
Karyopharm Therapeutics Inc
USWM, LLC (dba US WorldMeds)